CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 199 of 644
Non-Antibody Products
Page 199 of 644
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| D-Neopterin | An intermediate product in the synthetic pathway of biopterin that is rele… | 10 mg | 12057-10 | More Info |
| D-Neopterin | An intermediate product in the synthetic pathway of biopterin that is rele… | 100 mg | 12057-100 | More Info |
| D-Neopterin | An intermediate product in the synthetic pathway of biopterin that is rele… | 25 mg | 12057-25 | More Info |
| D-Neopterin | An intermediate product in the synthetic pathway of biopterin that is rele… | 50 mg | 12057-50 | More Info |
| D-NMAPPD | A ceramidase inhibitor; induces cell death in SW403 colon adenocarcinoma c… | 1 mg | 10006305-1 | More Info |
| D-NMAPPD | A ceramidase inhibitor; induces cell death in SW403 colon adenocarcinoma c… | 10 mg | 10006305-10 | More Info |
| D-NMAPPD | A ceramidase inhibitor; induces cell death in SW403 colon adenocarcinoma c… | 5 mg | 10006305-5 | More Info |
| D-NMAPPD | A ceramidase inhibitor; induces cell death in SW403 colon adenocarcinoma c… | 50 mg | 10006305-50 | More Info |
| D-NMMA (acetate) | The inactive enantiomer of L-NMMA used as a control compound to explore no… | 100 mg | 14186-100 | More Info |
| D-NMMA (acetate) | The inactive enantiomer of L-NMMA used as a control compound to explore no… | 25 mg | 14186-25 | More Info |
| D-NMMA (acetate) | The inactive enantiomer of L-NMMA used as a control compound to explore no… | 5 mg | 14186-5 | More Info |
| DNMT3B/DNMT3L Complex (human, recombinant) | Source: Active recombinant human N-terminal GST-tagged DNMT3B and N-termin… | 10 µg | 36311-10 | More Info |
| Dnp-GPLG | A negative control for use in MMP activity assays , | 1 mg | 24705-1 | More Info |
| Dnp-GPLGMRGL-NH2 (trifluoroacetate salt) | A peptide substrate for MMP-13 (kcat / Km = 4,200,000 M-1s-1), | 1 mg | 24701-1 | More Info |
| DNPH1i | A DNPH1 inhibitor; inhibits DNPH1 activity toward hmdU at 100 µM; re… | 1 mg | 38531-1 | More Info |
| DNPH1i | A DNPH1 inhibitor; inhibits DNPH1 activity toward hmdU at 100 µM; re… | 5 mg | 38531-5 | More Info |
| DNP-INT | An electron transport inhibitor in plants; competitively inhibits plastoqu… | 1 mg | 9003061-1 | More Info |
| DNP-INT | An electron transport inhibitor in plants; competitively inhibits plastoqu… | 10 mg | 9003061-10 | More Info |
| DNP-INT | An electron transport inhibitor in plants; competitively inhibits plastoqu… | 25 mg | 9003061-25 | More Info |
| DNP-INT | An electron transport inhibitor in plants; competitively inhibits plastoqu… | 5 mg | 9003061-5 | More Info |
| Dnp-P-Cha-Abu-Cys(Me)-HA-K(Nma)-NH2 | A fluorogenic substrate for MMP-1 and MMP-9; upon cleavage by MMP-1 or MMP… | 1 mg | 24664-1 | More Info |
| Dnp-P-Cha-G-Cys(Me)-HA-K(Nma)-NH2 (trifluoroacetate salt) | A fluorogenic substrate for MMP-1 and MMP-9; upon cleavage by MMP-1 or MMP… | 1 mg | 24709-1 | More Info |
| Dnp-PLALWAR (trifluoroacetate salt) | A fluorogenic substrate for MMP-1 and MMP-8; the activity of MMP-1 and MMP… | 1 mg | 24662-1 | More Info |
| Dnp-PLALWAR (trifluoroacetate salt) | A fluorogenic substrate for MMP-1 and MMP-8; the activity of MMP-1 and MMP… | 500 µg | 24662-500 | More Info |
| Dnp-PLAYWAR (trifluoroacetate salt) | A fluorogenic substrate for MMP-8 and MMP-26; activity of MMP-8 and MMP-26… | 1 mg | 24700-1 | More Info |
| Dnp-PLAYWAR (trifluoroacetate salt) | A fluorogenic substrate for MMP-8 and MMP-26; activity of MMP-8 and MMP-26… | 500 µg | 24700-500 | More Info |
| Dnp-PLG-Cys(Me)-HA-DArg-NH2 (trifluoroacetate salt) | A peptide substrate for MMP-1; improved kcat / Km ratio compared with Dnp-… | 1 mg | 24663-1 | More Info |
| Dnp-PLG-Cys(Me)-HA-DArg-NH2 (trifluoroacetate salt) | A peptide substrate for MMP-1; improved kcat / Km ratio compared with Dnp-… | 500 µg | 24663-500 | More Info |
| Dnp-PLGLWA-DArg-NH2 (trifluoroacetate salt) | A fluorogenic substrate for MMP-1, MMP-2, MMP-7, and MMP-9; activity of MM… | 1 mg | 24841-1 | More Info |
| Dnp-PLGMWSR (trifluoroacetate salt) | A fluorogenic substrate for MMP-2 and MMP-9; the activity of MMP-2 and MMP… | 1 mg | 24698-1 | More Info |
| Dnp-PLGMWSR (trifluoroacetate salt) | A fluorogenic substrate for MMP-2 and MMP-9; the activity of MMP-2 and MMP… | 500 µg | 24698-500 | More Info |
| Dnp-PYAYWMR (trifluoroacetate salt) | A fluorogenic heptapeptide substrate of MMP-8; tryptophan fluorescence is… | 1 mg | 24538-1 | More Info |
| Dnp-RPLALWRS (trifluoroacetate salt) | A fluorogenic substrate for MMP-7; activity of MMP-7 can be quantified by… | 1 mg | 24699-1 | More Info |
| Dnp-RPLALWRS (trifluoroacetate salt) | A fluorogenic substrate for MMP-7; activity of MMP-7 can be quantified by… | 500 µg | 24699-500 | More Info |
| DNQX | A competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1… | 10 mg | 14583-10 | More Info |
| DNQX | A competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1… | 100 mg | 14583-100 | More Info |
| DNQX | A competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1… | 25 mg | 14583-25 | More Info |
| DNQX | A competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1… | 50 mg | 14583-50 | More Info |
| DO264 | An ABHD12 inhibitor (IC50 = 11 nM); inhibits ABHD-dependent hydrolysis of… | 1 mg | 29402-1 | More Info |
| DO264 | An ABHD12 inhibitor (IC50 = 11 nM); inhibits ABHD-dependent hydrolysis of… | 10 mg | 29402-10 | More Info |
| DO264 | An ABHD12 inhibitor (IC50 = 11 nM); inhibits ABHD-dependent hydrolysis of… | 5 mg | 29402-5 | More Info |
| DOAM | An amphetamine that may act as an antagonist of the 5-HT2 receptor | 1 mg | 17656-1 | More Info |
| DOAM | An amphetamine that may act as an antagonist of the 5-HT2 receptor | 5 mg | 17656-5 | More Info |
| DOAM | An amphetamine that may act as an antagonist of the 5-HT2 receptor | 50 mg | 17656-50 | More Info |
| DOBU | An amphetamine that may act as an antagonist of the 5-HT2 receptor | 1 mg | 17655-1 | More Info |
| DOBU | An amphetamine that may act as an antagonist of the 5-HT2 receptor | 5 mg | 17655-5 | More Info |
| DOBU | An amphetamine that may act as an antagonist of the 5-HT2 receptor | 50 mg | 17655-50 | More Info |
| Dobutamine (hydrochloride) | A β-adrenergic receptor agonist with potent positive inotropic effect… | 10 mg | 15582-10 | More Info |
| Dobutamine (hydrochloride) | A β-adrenergic receptor agonist with potent positive inotropic effect… | 100 mg | 15582-100 | More Info |
| Dobutamine (hydrochloride) | A β-adrenergic receptor agonist with potent positive inotropic effect… | 5 mg | 15582-5 | More Info |
| Dobutamine (hydrochloride) | A β-adrenergic receptor agonist with potent positive inotropic effect… | 50 mg | 15582-50 | More Info |
| Docetaxel-d9 | An internal standard for the quantification of docetaxel by GC- or LC-MS | 1 mg | 22094-1 | More Info |
| Docetaxel-d9 | An internal standard for the quantification of docetaxel by GC- or LC-MS | 500 µg | 22094-500 | More Info |
| Docetaxel (hydrate) | A microtubule-stabilizing agent; promotes microtubule assembly in a cell-f… | 10 mg | 11637-10 | More Info |
| Docetaxel (hydrate) | A microtubule-stabilizing agent; promotes microtubule assembly in a cell-f… | 250 mg | 11637-250 | More Info |
| Docetaxel (hydrate) | A microtubule-stabilizing agent; promotes microtubule assembly in a cell-f… | 5 mg | 11637-5 | More Info |
| Docetaxel (hydrate) | A microtubule-stabilizing agent; promotes microtubule assembly in a cell-f… | 50 mg | 11637-50 | More Info |
| Docetaxel Polymeric Nanoparticles | A docetaxel-based PNP formulation,, | 2 mg | 39769-2 | More Info |
| Docosadienoic Acid methyl ester | An esterified version of docosadienoic acid ,, | 10 mg | 20602-10 | More Info |
| Docosadienoic Acid methyl ester | An esterified version of docosadienoic acid ,, | 25 mg | 20602-25 | More Info |
| Docosadienoic Acid methyl ester | An esterified version of docosadienoic acid ,, | 5 mg | 20602-5 | More Info |
| Docosaenoyl Ethanolamide | A long-chain ethanolamine that occurs at relatively high levels in rat CSF… | 10 mg | 9001745-10 | More Info |
| Docosaenoyl Ethanolamide | A long-chain ethanolamine that occurs at relatively high levels in rat CSF… | 5 mg | 9001745-5 | More Info |
| Docosaenoyl Ethanolamide | A long-chain ethanolamine that occurs at relatively high levels in rat CSF… | 50 mg | 9001745-50 | More Info |
| Docosahexaenoic Acid | A long-chain ω-3 PUFA; comprises approximately 40% of total brain PU… | 100 mg | 90310-100 | More Info |
| Docosahexaenoic Acid | A long-chain ω-3 PUFA; comprises approximately 40% of total brain PU… | 250 mg | 90310-250 | More Info |
| Docosahexaenoic Acid | A long-chain ω-3 PUFA; comprises approximately 40% of total brain PU… | 50 mg | 90310-50 | More Info |
| Docosahexaenoic Acid | A long-chain ω-3 PUFA; comprises approximately 40% of total brain PU… | 500 mg | 90310-500 | More Info |
| Docosahexaenoic Acid Alkyne | An ω-alkyne derivative of docosahexaenoic acid; can be joined with a… | 100 µg | 16689-100 | More Info |
| Docosahexaenoic Acid Alkyne | An ω-alkyne derivative of docosahexaenoic acid; can be joined with a… | 500 µg | 16689-500 | More Info |
| Docosahexaenoic Acid 1,2,3,4-13C | An internal standard for the quantification of DHA by GC- or LC-MS | 100 µg | 31104-100 | More Info |
| Docosahexaenoic Acid 1,2,3,4-13C | An internal standard for the quantification of DHA by GC- or LC-MS | 25 µg | 31104-25 | More Info |
| Docosahexaenoic Acid 1,2,3,4-13C | An internal standard for the quantification of DHA by GC- or LC-MS | 250 µg | 31104-250 | More Info |
| Docosahexaenoic Acid 1,2,3,4-13C | An internal standard for the quantification of DHA by GC- or LC-MS | 50 µg | 31104-50 | More Info |
| Docosahexaenoic Acid CYP450 Oxylipins MaxSpec® LC-MS Mixture | A mixture that contains (±)7(8)-EpDPA, (±)10(11)-EpDPA, (&pl… | 1 ea | 22639-1 | More Info |
| Docosahexaenoic Acid-d5 | An internal standard for the quantification of DHA by GC- or LC-MS | 1 mg | 10005057-1 | More Info |
| Docosahexaenoic Acid-d5 | An internal standard for the quantification of DHA by GC- or LC-MS | 100 µg | 10005057-100 | More Info |
| Docosahexaenoic Acid-d5 | An internal standard for the quantification of DHA by GC- or LC-MS | 50 µg | 10005057-50 | More Info |
| Docosahexaenoic Acid-d5 | An internal standard for the quantification of DHA by GC- or LC-MS | 500 µg | 10005057-500 | More Info |
| Docosahexaenoic Acid-d5 ethyl ester | An internal standard for the quantification of docosahexaenoic acid ethyl… | 100 µg | 37971-100 | More Info |
| Docosahexaenoic Acid-d5 ethyl ester | An internal standard for the quantification of docosahexaenoic acid ethyl… | 250 µg | 37971-250 | More Info |
| Docosahexaenoic Acid-d5 ethyl ester | An internal standard for the quantification of docosahexaenoic acid ethyl… | 500 µg | 37971-500 | More Info |
| Docosahexaenoic Acid-d5 MaxSpec® Standard | A quantitative analytical standard guaranteed to meet MaxSpec® identit… | 100 µg | 27357-100 | More Info |
| Docosahexaenoic Acid-d5 methyl ester | An internal standard for the quantification of DHA methyl ester by GC- or… | 1 mg | 31125-1 | More Info |
| Docosahexaenoic Acid-d5 methyl ester | An internal standard for the quantification of DHA methyl ester by GC- or… | 100 µg | 31125-100 | More Info |
| Docosahexaenoic Acid ethyl ester | An esterified form of DHA; increases plasma and erythrocyte membrane DHA l… | 1 g | 9090310-1 | More Info |
| Docosahexaenoic Acid ethyl ester | An esterified form of DHA; increases plasma and erythrocyte membrane DHA l… | 100 mg | 9090310-100 | More Info |
| Docosahexaenoic Acid ethyl ester | An esterified form of DHA; increases plasma and erythrocyte membrane DHA l… | 50 mg | 9090310-50 | More Info |
| Docosahexaenoic Acid ethyl ester | An esterified form of DHA; increases plasma and erythrocyte membrane DHA l… | 500 mg | 9090310-500 | More Info |
| Docosahexaenoic Acid ethyl ester-d5 | An internal standard for the quantification of docosahexaenoic acid ethyl… | 1 mg | 9001245-1 | More Info |
| Docosahexaenoic Acid ethyl ester-d5 | An internal standard for the quantification of docosahexaenoic acid ethyl… | 100 µg | 9001245-100 | More Info |
| Docosahexaenoic Acid ethyl ester-d5 | An internal standard for the quantification of docosahexaenoic acid ethyl… | 50 µg | 9001245-50 | More Info |
| Docosahexaenoic Acid ethyl ester-d5 | An internal standard for the quantification of docosahexaenoic acid ethyl… | 500 µg | 9001245-500 | More Info |
| Docosahexaenoic Acid MaxSpec® Standard | A quantitative analytical standard guaranteed to meet MaxSpec® identit… | 1 mg | 26414-1 | More Info |
| Docosahexaenoic Acid methyl ester | An esterified form of DHA; has been used as a reference standard in the qu… | 100 mg | 10006865-100 | More Info |
| Docosahexaenoic Acid methyl ester | An esterified form of DHA; has been used as a reference standard in the qu… | 1000 mg | 10006865-1 | More Info |
| Docosahexaenoic Acid methyl ester | An esterified form of DHA; has been used as a reference standard in the qu… | 50 mg | 10006865-50 | More Info |
| Docosahexaenoic Acid methyl ester | An esterified form of DHA; has been used as a reference standard in the qu… | 500 mg | 10006865-500 | More Info |
| Docosahexaenoic Acid Quant-PAK | The DHA Quant-PAK has been designed for the convenient, precise quantifica… | 1 ea | 10006829-1EA | More Info |
| Docosahexaenoyl Ethanolamide | The ethanolamine amide of DHA that has been detected in both brain and ret… | 10 mg | 10007534-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile